ZIVO Bioscience, Inc.

ZIVO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023
Assets
Cash & Equivalents $57.2K $9.8K $517.2K $1.5M $159.4K $2.5K $138.6K $274.4K
Accounts Receivable — — — — — — — —
Inventory — — — — — — — —
Total Current Assets $281.4K $409.9K $1.0M $1.6M $436.5K $495.1K $710.6K $425.4K
Property, Plant & Equipment — — — — — — — $0
Goodwill — — — — — — — —
Intangible Assets (Excl. Goodwill) — — — — — — — —
Total Assets $559.5K $703.3K $1.3M $1.6M $495.6K $575.6K $816.4K $555.7K
Liabilities
Accounts Payable $993.0K $860.9K $655.3K $547.1K $787.6K $1.1M $705.8K $993.1K
Total Current Liabilities $3.6M $3.0M $2.6M $2.0M $2.6M $2.9M $3.1M $2.8M
Long-Term Debt — — — — — — — —
Total Liabilities $3.8M $3.2M $2.9M $2.2M $2.6M $2.9M $3.1M $2.8M
Stockholders' Equity
Retained Earnings $-143.9M $-142.8M $-141.2M $-137.0M $-135.4M $-133.1M $-124.9M $-123.6M
Total Stockholders' Equity $-3.3M $-2.5M $-1.6M $-514.9K $-2.1M $-2.3M $-2.3M $-2.2M
← Newer Page 1 of 8 Older →